At Symmetry Pharma, the function of Research and Development goes far beyond the technical process of developing new drugs to add to our portfolio. Our focus is guided by the needs of our patients, and so the process of creating and launching new drugs begins with understanding which medicines are most needed in the market today.
Our product pipeline proposals are carefully reviewed by committees that comprise department heads and consultants. Ideas are carefully scrutinized and evaluated according to a wide range of criteria whose purpose is to ensure the introduction of safe drugs that fulfill market needs.
Once a product candidate has met our criteria, we develop an alternative guided by the principle of enhancing efficacy by searching for and leveraging new drug delivery systems as opposed to simply replicating a product.
We achieve our mandate of excellence by regularly upgrading our R&D laboratories and facilities with special equipment and state-of-the-art instruments while entrusting their operation to an exceptional team of professionals.
As of July 2021, Symmetry Pharma’s product portfolio consists of 5 in-market products and over 25 in the pipeline.